These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31483053)

  • 21. Immunohistochemical expression of GPR30 in breast carcinoma of Egyptian patients: an association with immunohistochemical subtypes.
    Aiad HA; Wahed MM; Asaad NY; El-Tahmody M; Elhosary E
    APMIS; 2014 Oct; 122(10):976-84. PubMed ID: 24628533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone.
    Heino TJ; Chagin AS; Sävendahl L
    J Endocrinol; 2008 May; 197(2):R1-6. PubMed ID: 18434348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
    Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro.
    Fan DX; Yang XH; Li YN; Guo L
    Med Sci Monit; 2018 Apr; 24():1936-1947. PubMed ID: 29608013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G protein-coupled estrogen receptor 1 expression in human vocal fold.
    Wu D; Jiang JJ; Fang R; Swinarski K; Cui X
    Laryngoscope; 2013 Apr; 123(4):948-51. PubMed ID: 23494473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of various clones of estrogen receptor in cell block preparation of lung adenocarcinoma.
    Hakima L; Schlesinger K; Sunkara J; Karabakhtsian RG
    Diagn Cytopathol; 2018 May; 46(5):390-394. PubMed ID: 29465823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nestin: A biomarker of aggressive uterine cancers.
    Hope ER; Mhawech-Fauceglia P; Pejovic T; Zahn CM; Wang G; Conrads TP; Larry Maxwell G; Hamilton CA; Darcy KM; Syed V
    Gynecol Oncol; 2016 Mar; 140(3):503-11. PubMed ID: 26718725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
    Lu X; Toki T; Konishi I; Nikaido T; Fujii S
    Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
    Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
    J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
    Ignatov A; Ignatov T; Weissenborn C; Eggemann H; Bischoff J; Semczuk A; Roessner A; Costa SD; Kalinski T
    Breast Cancer Res Treat; 2011 Jul; 128(2):457-66. PubMed ID: 21607586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
    Ueda A; Takasawa A; Akimoto T; Takasawa K; Aoyama T; Ino Y; Nojima M; Ono Y; Murata M; Osanai M; Hasegawa T; Saito T; Sawada N
    PLoS One; 2017; 12(8):e0184123. PubMed ID: 28859123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study.
    Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Piechota-Polańczyk A; Stec-Michalska K; Krajewska WM; Fichna J; Wiśniewska-Jarosińska M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):29-35. PubMed ID: 28338111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma.
    Elfeky M; Harb O; Gertallah L
    Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
    Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
    Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
    Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
    Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation between GPR30 and clinicopathologic variables in breast carcinomas.
    Tu G; Hu D; Yang G; Yu T
    Technol Cancer Res Treat; 2009 Jun; 8(3):231-4. PubMed ID: 19445541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR30 estrogen receptor expression in the growth plate declines as puberty progresses.
    Chagin AS; Sävendahl L
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4873-7. PubMed ID: 17878253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.